Diaverum and Nipro seal long-term and mutually value-adding partnership
On 24 April, a delegation from Diaverum led by the company’s CEO, Mr. Dimitris Moulavasilis, met with Nipro’s President, Mr. Yoshihiko Sano, at the new Nipro Corporation Japan headquarters in Osaka, Japan, to mark the signing and official commencement of a prolonged partnership between the parties.
Diaverum and Nipro are committed to further strengthening ties and exploring long-term opportunities for continued and diversified collaboration in many areas, reinforcing Nipro’s role as a strategic partner of Diaverum. The concept of “Value-Based-Care” resonates with both companies, who share the ultimate goal of delivering the best possible patient outcomes by providing efficient, holistic, and adequate treatment solutions.
Dimitris Moulavasilis, Diaverum CEO, said: “We value Nipro as a strategic partner for its comprehensive portfolio, good logistics, and extensive field presence globally. This long-term and wider scope partnership with Nipro will strengthen our ability to manage inflationary pressures and enjoy efficiencies in strategic areas, ultimately benefiting patients and healthcare systems worldwide”.
Yoshihiko Sano, Nipro President, said: “We have been working with Diaverum since 2008, supporting the healthcare organisation with high-value products and reliable customer service. As well as an extension of the partnership, the number and types of products that would be supplied have also expanded.”
About Nipro:
Nipro Medical Europe is part of Nipro Corporation Japan, a leading global healthcare company established in 1954. With over 35,000 employees worldwide, Nipro serves the Medical Device, Pharmaceutical, and Pharmaceutical Packaging industries.
About Diaverum:
Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives. As a global leader and the largest independent renal service provider in Europe, it cares for around 39,000 patients across 440 clinics in 23 countries globally.
Marianna Sofocleous
Global Communications & Editorial Manager
marianna.sofocleous@diaverum.com
About Diaverum
Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives.
Our vision is to transform the industry through patient-centric digital innovations, delivering and broadening access to the highest quality of care.
Our focus is to provide renal care tailored to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to coordination of patients’ comorbidities and holiday dialysis.
As a global leader and the largest independent renal service provider in Europe, we care for around 39,000 patients across 440 clinics in 23 countries globally. Diaverum employs around 13,000 people worldwide and is headquartered in Malmö, Sweden.
